ArticleOncoTargets and therapy2014

Outcomes analysis of an alternative formulation of PEGylated liposomal doxorubicin in recurrent epithelial ovarian carcinoma during the drug shortage era.

Jessica L Berger et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.